Literature DB >> 19619704

The paradoxical use of cardiac catheterization in patients with non-ST-elevation acute coronary syndromes: lessons from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC /AHA Guidelines (CRUSADE) Quality Improvement Initiative.

Mauricio G Cohen1, Steven J Filby, Matthew T Roe, Anita Y Chen, Venu Menon, George A Stouffer, W Brian Gibler, Sidney C Smith, Charles V Pollack, Eric D Peterson, E Magnus Ohman.   

Abstract

BACKGROUND: The long-term benefits of coronary revascularization are proportional to the severity of underlying coronary artery disease (CAD). We sought to identify patients with a greater probability of severe CAD to target those who could receive the greatest benefit from revascularization.
METHODS: We used multivariable logistic generalized estimating equations modeling to identify clinical factors associated with severe CAD in 83,490 patients, without prior bypass surgery, who underwent coronary angiography after presenting with non-ST-segment elevation acute coronary syndromes enrolled in CRUSADE. We then compared actual patterns of cardiac catheterization use relative to patients' probability of severe CAD in those who underwent catheterization and those who did not.
RESULTS: Independent factors associated with severe CAD included older age, male sex, diabetes, no prior percutaneous coronary intervention, signs or history of heart failure, prior myocardial infarction, ST-segment depression, and family history of CAD. Cardiac catheterization rates were inversely related to the probability of severe CAD as estimated by the model.
CONCLUSIONS: There is a misalignment in the use of cardiac catheterization in patients with non-ST-segment elevation acute coronary syndromes relative to their predicted probability of severe CAD. The use of catheterization appears to target patients who would derive less benefit from revascularization. Further quality improvement efforts should promote appropriate use of cardiac catheterization procedures among patients with the greatest potential benefit.

Entities:  

Mesh:

Year:  2009        PMID: 19619704     DOI: 10.1016/j.ahj.2009.05.016

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  14 in total

Review 1.  Routine invasive versus conservative management in non-ST-elevation acute coronary syndromes.

Authors:  Peter R Sinnaeve
Journal:  J Cardiovasc Transl Res       Date:  2011-11-01       Impact factor: 4.132

2.  High risk percutaneous coronary interventions-significance of left ventricular assist device for clinical practice.

Authors:  Vladimir Ganyukov; Roman Tarasov
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

Review 3.  Diabetes mellitus and acute coronary syndrome: lessons from randomized clinical trials.

Authors:  Sanjum S Sethi; Elias G Akl; Michael E Farkouh
Journal:  Curr Diab Rep       Date:  2012-06       Impact factor: 4.810

4.  Baseline characteristics, management practices, and in-hospital outcomes of patients with acute coronary syndromes: Results of the Saudi project for assessment of coronary events (SPACE) registry.

Authors:  Khalid F Alhabib; Ahmad Hersi; Hussam Alfaleh; Khalid Alnemer; Shukri Alsaif; Amir Taraben; Tarek Kashour; Anas Bakheet; Ayed Al Qarni; Tariq Soomro; Asif Malik; Waqar H Ahmed; Ahmed M Abuosa; Modaser A Butt; Mushabab A Almurayeh; Abdulaziz Al Zaidi; Gamal A Hussein; Mohammed A Balghith; Tareg Abu-Ghazala
Journal:  J Saudi Heart Assoc       Date:  2011-06-01

Review 5.  Risk stratification and timing of revascularization: which patients benefit from early versus later revascularization?

Authors:  Ian J Sarembock; Dean J Kereiakes
Journal:  Curr Cardiol Rep       Date:  2012-08       Impact factor: 2.931

6.  Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention.

Authors:  Ajay J Kirtane; Darshan Doshi; Martin B Leon; John M Lasala; E Magnus Ohman; William W O'Neill; Adhir Shroff; Mauricio G Cohen; Igor F Palacios; Nirat Beohar; Nir Uriel; Navin K Kapur; Dimitri Karmpaliotis; William Lombardi; George D Dangas; Manish A Parikh; Gregg W Stone; Jeffrey W Moses
Journal:  Circulation       Date:  2016-08-02       Impact factor: 39.918

7.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial.

Authors:  Stefan K James; Matthew T Roe; Christopher P Cannon; Jan H Cornel; Jay Horrow; Steen Husted; Hugo Katus; Joao Morais; Ph Gabriel Steg; Robert F Storey; Susanna Stevens; Lars Wallentin; Robert A Harrington
Journal:  BMJ       Date:  2011-06-17

8.  Underuse of an invasive strategy for patients with diabetes with acute coronary syndrome: a nationwide study.

Authors:  Ida Gustafsson; Anders Hvelplund; Kim Wadt Hansen; Søren Galatius; Mette Madsen; Jan Skov Jensen; Hans-Henrik Tilsted; Christian Juhl Terkelsen; Lisette Okkels Jensen; Erik Jørgensen; Jan Kyst Madsen; Steen Zabell Abildstrøm
Journal:  Open Heart       Date:  2015-02-06

9.  Prognostic value of shock index in patients admitted with non-ST-segment elevation myocardial infarction: the ARIC study community surveillance.

Authors:  Zainali S Chunawala; Michael E Hall; Sameer Arora; Xuming Dai; Venu Menon; Sidney C Smith; Kunihiro Matsushita; Melissa C Caughey
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2021-10-27

10.  Outcomes According to Cardiac Catheterization Referral and Clopidogrel Use Among Medicare Patients With Non-ST-Segment Elevation Myocardial Infarction Discharged Without In-hospital Revascularization.

Authors:  Connie N Hess; Anne S Hellkamp; Matthew T Roe; Laine Thomas; Benjamin M Scirica; S Andrew Peng; Eric D Peterson; Tracy Y Wang
Journal:  J Am Heart Assoc       Date:  2016-03-14       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.